The Beauty Health Company

SKIN

US88331L1089

Personal Products

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-10 pm EDT			5-day change	1st Jan Change
2.74 ^USD	-23.68%		-18.45%	-11.90%

May. 09	(SKIN) THE BEAUTY HEALTH COMPANY Forecasts Q2 Revenue Range $96M - $102M	MT
May. 09	Earnings Flash (SKIN) THE BEAUTY HEALTH COMPANY Reports Q1 Revenue $81.4M, vs. Street Est of $80.7M	MT

The Beauty Health Company(NasdaqCM:SKIN) added to S&P Global BMI Index

September 20, 2021 at 12:00 am EDT

Latest news about The Beauty Health Company

(SKIN) THE BEAUTY HEALTH COMPANY Forecasts Q2 Revenue Range $96M - $102M	May. 09	MT
Earnings Flash (SKIN) THE BEAUTY HEALTH COMPANY Reports Q1 Revenue $81.4M, vs. Street Est of $80.7M	May. 09	MT
Beauty Health Names Sheri Lewis as Chief Supply Chain, Operations Officer	Apr. 10	MT
The Beauty Health Company Announces Termination of Brad Hauser as Chief Operating Officer	Apr. 09	CI
Beauty Health Company Appoints Sheri Lewis as Chief Supply Chain and Operations Officer	Apr. 09	CI
Canaccord Genuity Adjusts Price Target on The Beauty Health to $4 From $3, Maintains Hold Rating	Mar. 14	MT
Top Midday Gainers	Mar. 13	MT
Global markets live: Adidas, EON, Sandoz, Bayer, Boeing...	Mar. 13
Beauty Health Shares Rise After Q4 Beat; Names Beck Permanent CEO	Mar. 13	MT
Stifel Raises Price Target on The Beauty Health to $4 From $3, Maintains Hold Rating	Mar. 13	MT
Not a care in the world	Mar. 13
Sector Update: Consumer Stocks Slip Pre-Bell Wednesday	Mar. 13	MT
TD Cowen Adjusts Price Target on The Beauty Health to $4 From $2.50, Maintains Market Perform Rating	Mar. 13	MT
Traders Turn Cautious Ahead of Economic Data, Driving Muted Premarket Action for US Equity Futures	Mar. 13	MT
Piper Sandler Adjusts Beauty Health's Price Target to $3 From $2, Maintains Underweight Rating	Mar. 13	MT
Top Premarket Gainers	Mar. 13	MT
Beauty Health Reports Q4 Loss, Lower Sales; Names Beck Permanent CEO -- Shares Rise After-Hours	Mar. 12	MT
Tranche Update on The Beauty Health Company's Equity Buyback Plan announced on September 12, 2023.	Mar. 12	CI
The Beauty Health Company Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 12	CI
Transcript : The Beauty Health Company, Q4 2023 Earnings Call, Mar 12, 2024	Mar. 12
Earnings Flash (SKIN) THE BEAUTY HEALTH COMPANY Reports Q4 Revenue $96.8M, vs. Street Est of $87.6M	Mar. 12	MT
(SKIN) THE BEAUTY HEALTH COMPANY Expects Q1 Revenue Range $77M - $83M	Mar. 12	MT
The Beauty Health Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 12	CI
The Beauty Health Company Provides Earnings Guidance for First Quarter and Full Year 2024	Mar. 12	CI
The Beauty Health Company Announces Appointment of Marla Beck as Chief Executive Officer	Mar. 12	CI

Chart The Beauty Health Company

Duration

Period

More charts

The Beauty Health Company is a global category-creating company delivering skin health experiences. The Company and its subsidiaries design, develop, manufacture, market, and sell esthetic technologies and products. The Company is personalizing skin health for all ages, genders, skin tones, and skin types. Its brands include Hydrafacial, SkinStylus and Keravive. Hydrafacial created the category of hydradermabrasion with its patented delivery system (Delivery System) that cleanses, extracts, and hydrates the skin with proprietary solutions and serums. SkinStylus specializes in microneedling with its products that are designed to provide a minimally-invasive microneedling skin treatment to help stimulate collagen and elastin production. Keravive specializes in scalp health with its products that are designed to cleanse, exfoliate, and hydrate the scalp and hair follicles. Hydrafacial's primary product offerings are the Syndeo device and its associated serum solutions and consumables.

Sector

Personal Products

Calendar

2024-06-06 - Annual General Meeting

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for The Beauty Health Company

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

2.74 USD

Average target price

3.767 USD

Spread / Average Target

+37.47%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Cosmetics & Perfumes

	1st Jan change	Capi.
THE BEAUTY HEALTH COMPANY	-11.90%	443M
L'ORÉAL	+0.62%	261B
KAO CORPORATION	+19.64%	19.93B
GALDERMA GROUP AG	0.00%	18.65B
SHISEIDO COMPANY, LIMITED	+6.07%	11.53B
COTY INC.	-10.06%	9.7B
AMOREPACIFIC CORPORATION	+17.79%	7.6B
PROYA COSMETICS CO.,LTD.	+14.08%	6.32B
NATURA &CO HOLDING S.A.	+2.13%	4.71B
INTER PARFUMS, INC.	-15.27%	3.86B

Cosmetics & Perfumes